Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis (2d-BR)
Primary Purpose
Healthy
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Habitual activity
Bed rest
Sponsored by
About this trial
This is an interventional basic science trial for Healthy
Eligibility Criteria
Inclusion Criteria:
- Male
- Aged 18-40
Exclusion Criteria:
- Smoker
- Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
- Any diagnosed cardiovascular disease (e.g. deep vein thrombosis or hypertension)
- Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism).
- A personal or family history of thrombosis, epilepsy, seizures or schizophrenia.
- Any known disorders in muscle metabolism
- Regular use of nutritional supplements (i.e. ingestion more than twice per week during the last month)
- Metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws).
- Allergy to lidocaine
- Recent (within the last 6 months) or current musculoskeletal injury (e.g. leg fracture)
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Habitual activity and 2 days bed rest
Arm Description
Participants will undergo 2 days of habitual activity and 2 days bed rest
Outcomes
Primary Outcome Measures
Change in whole-body insulin sensitivity
Change in whole-body insulin sensitivity via meal tolerance test
Secondary Outcome Measures
Change in cumulative muscle protein synthesis
Cumulative muscle protein synthesis via deuterium oxide ingestion. The incorporation of deuterated alanine in muscle is expressed relative to body water enrichments, to obtain muscle protein synthesis in %/day
Change in continuous glucose
Change in continuous glucose via continuous glucose monitoring.
Change in muscle volume
Change in muscle volume via MRI
Full Information
NCT ID
NCT03877822
First Posted
February 28, 2019
Last Updated
November 9, 2021
Sponsor
University of Exeter
1. Study Identification
Unique Protocol Identification Number
NCT03877822
Brief Title
Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis
Acronym
2d-BR
Official Title
The Impact of Two Days of Bed Rest Versus Two Days of Habitual Activity on Insulin Sensitivity and Cumulative Muscle Protein Synthesis in Healthy Young Males
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Withdrawn
Why Stopped
Study protocol no longer relevant after progression of the scientific field
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
September 1, 2021 (Actual)
Study Completion Date
September 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Exeter
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The impact of two days bed rest versus two days of habitual activity on insulin sensitivity and cumulative muscle protein synthesis will be investigated in healthy young males
Detailed Description
To study the mechanisms underlying inactivity-induced muscle atrophy, the impact of two days bed rest versus two days of habitual activity on insulin sensitivity and cumulative muscle protein synthesis will be investigated in healthy young males
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Participants will firstly undergo 2 days of habitual physical activity, followed by 2 days of bed rest
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Habitual activity and 2 days bed rest
Arm Type
Experimental
Arm Description
Participants will undergo 2 days of habitual activity and 2 days bed rest
Intervention Type
Behavioral
Intervention Name(s)
Habitual activity
Intervention Description
Two days of habitual physical activity, under normal free-living conditions
Intervention Type
Behavioral
Intervention Name(s)
Bed rest
Intervention Description
Two days of bed rest, to induce whole-body physical inactivity
Primary Outcome Measure Information:
Title
Change in whole-body insulin sensitivity
Description
Change in whole-body insulin sensitivity via meal tolerance test
Time Frame
During 2 days of habitual physical activity and 2 days of bed rest. Blood glucose and insulin are monitored for 2 hours following ingestion of a standardized meal
Secondary Outcome Measure Information:
Title
Change in cumulative muscle protein synthesis
Description
Cumulative muscle protein synthesis via deuterium oxide ingestion. The incorporation of deuterated alanine in muscle is expressed relative to body water enrichments, to obtain muscle protein synthesis in %/day
Time Frame
During 2 days of habitual physical activity and 2 days of bed rest
Title
Change in continuous glucose
Description
Change in continuous glucose via continuous glucose monitoring.
Time Frame
Continuous glucose, during the 2 days of habitual activity and 2 days of bed rest
Title
Change in muscle volume
Description
Change in muscle volume via MRI
Time Frame
Immediately before and immediately after the 2-day bed rest period
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male
Aged 18-40
Exclusion Criteria:
Smoker
Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
Any diagnosed cardiovascular disease (e.g. deep vein thrombosis or hypertension)
Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism).
A personal or family history of thrombosis, epilepsy, seizures or schizophrenia.
Any known disorders in muscle metabolism
Regular use of nutritional supplements (i.e. ingestion more than twice per week during the last month)
Metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws).
Allergy to lidocaine
Recent (within the last 6 months) or current musculoskeletal injury (e.g. leg fracture)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marlou L Dirks, PhD
Organizational Affiliation
University of Exeter
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis
We'll reach out to this number within 24 hrs